Wednesday, June 22, 2011

Smoking makes prostate cancer deadlier: U.S. study

Smoking makes prostate cancer deadlier:

U.S. study: "CHICAGO (Reuters) -

Smoking increases the risk that men who develop prostate cancer will die from their disease, U.S. researchers said on Tuesday.

"We compared current smokers to never smokers. Compared to never smokers, current smokers had a 61 percent increased risk of dying of prostate cancer, as well as a 61 percent increased risk of having their cancer return,"

Compared with current smokers, men who had quit for 10 or more years had about the same risk of dying from their prostate cancer as those who had never smoked, Kenfield and colleagues found.


"

Tuesday, June 21, 2011

New cancer vaccine for Prostate Cancer

New method tested as cancer vaccine:

"BBC News has reported that a vaccine offers hope for prostate cancer sufferers. The broadcaster reported on a new approach to developing cancer vaccines in which “DNA from healthy cells was used to create a vaccine which cured 80% of mice”.

It is far too early to suggest that this experimental study offers hope for a vaccine against prostate cancer or any other cancer.

Thursday, June 16, 2011

Impotence Linked to Restless Legs Syndrome (HealthDay)

Impotence Linked to Restless Legs Syndrome
(HealthDay)


HealthDay - WEDNESDAY, June 15 (HealthDay News) --

Men who struggle with restless legs syndrome face a higher risk of impotence, a new study suggests.

Men who experienced restless legs syndrome symptoms up to 14 times a month were 68 percent more likely to struggle with erectile dysfunction, the study found.

The research was presented at SLEEP 2011, the annual meeting of the Associated Professional Sleep Societies, in Minneapolis. Because the study was presented at a medical meeting, the conclusions should be viewed as preliminary until published in a peer-reviewed journal.


Friday, June 10, 2011

Prostate drugs raise risk of prostate cancer: FDA

Prostate drugs raise risk of prostate cancer: FDA:

"WASHINGTON (Reuters) - A class of drugs meant to improve symptoms of an enlarged prostate gland actually increase the chance of getting a more serious form of prostate cancer, health officials said on Thursday.

The drugs in this group include Merck & Co's Proscar and GlaxoSmithKline's Avodar and Jalyn, as well as Merck's Propecia, which is approved to treat male pattern hair loss.

The Food and Drug Administration said it revised the labels on all such drugs, called 5-alpha reductase inhibitors (5-ARI), to include the risk after reviewing two large studies.

However, they also said the drugs' benefits outweigh the risks.





"

Wednesday, June 8, 2011

Safe to skip radiation for prostate cancer?

Safe to skip radiation for prostate cancer?

"NEW YORK (Reuters Health) -

A review of recent studies comparing different radiation treatments for prostate cancer reveals no clear picture of what works best for the majority of men with the disease.


"

Saturday, June 4, 2011

Incontinence after prostate surgery no big deal: men

Incontinence after prostate surgery no big deal

"NEW YORK (Reuters Health) -

Many men have some degree of incontinence after prostate surgery, but few are significantly bothered by it, according to a poll at one U.S. hospital.

Prostate removal is usually only recommended for men who are expected to live at least 10 to 15 more years. And even then, the decision should be based on individual preferences.

For instance, if a man already has some incontinence and impotence, surgery would be a good choice . But if he is very worried about impotence, radiation treatment might be a better way to go, because its effect on continence and potency are delayed a few years.




"

Thursday, June 2, 2011

Cholesterol drugs tied to lower prostate cancer risk (Reuters)

Cholesterol drugs tied to lower prostate cancer risk
(Reuters)
:

Men taking cholesterol-lowering medication may be less likely to get prostate cancer than those not on the drugs, suggests a new study."

The finding can't prove that the drugs, called statins, lower the risk of prostate cancer, and the authors note that there is still some controversy about if and how statins affect a man's chance of getting prostate cancer.